These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24652495)

  • 21. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium.
    Miller L; Patton DL; Meier A; Thwin SS; Hooton TM; Eschenbach DA
    Obstet Gynecol; 2000 Sep; 96(3):431-9. PubMed ID: 10960638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1.
    Quispe Calla NE; Vicetti Miguel RD; Torres AR; Trout W; Gabriel JM; Hatfield AM; Aceves KM; Kwiek JJ; Kaur B; Cherpes TL
    Immunohorizons; 2020 Feb; 4(2):72-81. PubMed ID: 32047094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk.
    Butler K; Ritter JM; Ellis S; Morris MR; Hanson DL; McNicholl JM; Kersh EN
    J Acquir Immune Defic Syndr; 2016 Aug; 72(4):363-71. PubMed ID: 27355414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in key vaginal bacteria among postpartum African women initiating intramuscular depot-medroxyprogesterone acetate.
    Whitney BM; Guthrie BL; Srinivasan S; Tapia K; Muriuki EM; Chohan BH; Wallis JM; Liu C; McClelland RS; Fredricks DN; Roxby AC
    PLoS One; 2020; 15(3):e0229586. PubMed ID: 32134931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques.
    Butler K; Ritter J; Ellis S; Henning TR; Montague J; Zaki S; Garber D; McNicholl JM; Kersh EN
    J Med Primatol; 2015 Oct; 44(5):286-95. PubMed ID: 26238265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections.
    Dabee S; Balle C; Onono M; Innes S; Nair G; Palanee-Phillips T; Burgener AD; Bosinger SE; Passmore JS; Heffron R; Jaspan H; Happel AU
    Curr HIV/AIDS Rep; 2023 Aug; 20(4):251-260. PubMed ID: 37341916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.
    Weinberg A; Park JG; Bosch R; Cho A; Livingston E; Aweeka F; Cramer Y; Watts DH; Luque AE; Cohn SE
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):137-45. PubMed ID: 26413850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal microbiome-hormonal contraceptive interactions associate with the mucosal proteome and HIV acquisition.
    Noël-Romas L; Perner M; Molatlhegi R; Farr Zuend C; Mabhula A; Hoger S; Lamont A; Birse K; Berard A; McCorrister S; Westmacott G; Leslie A; Poliquin V; Heffron R; McKinnon LR; Burgener AD
    PLoS Pathog; 2020 Dec; 16(12):e1009097. PubMed ID: 33362285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of contraceptive initiation on vaginal microbiota.
    Achilles SL; Austin MN; Meyn LA; Mhlanga F; Chirenje ZM; Hillier SL
    Am J Obstet Gynecol; 2018 Jun; 218(6):622.e1-622.e10. PubMed ID: 29505773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission.
    van de Wijgert JH; Verwijs MC; Turner AN; Morrison CS
    AIDS; 2013 Aug; 27(13):2141-53. PubMed ID: 23660575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women.
    Guthrie BL; Introini A; Roxby AC; Choi RY; Bosire R; Lohman-Payne B; Hirbod T; Farquhar C; Broliden K
    J Acquir Immune Defic Syndr; 2015 May; 69(1):1-10. PubMed ID: 25622059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Resolution Quantitative Mapping of Macaque Cervicovaginal Epithelial Thickness: Implications for Mucosal Vaccine Delivery.
    Vincent KL; Frost PA; Motamedi M; Dick EJ; Wei J; Yang J; White R; Gauduin MC
    Front Immunol; 2021; 12():660524. PubMed ID: 34262561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract.
    Carias AM; Allen SA; Fought AJ; Kotnik Halavaty K; Anderson MR; Jimenez ML; McRaven MD; Gioia CJ; Henning TR; Kersh EN; Smith JM; Pereira LE; Butler K; McNicholl SJ; Hendry RM; Kiser PF; Veazey RS; Hope TJ
    PLoS Pathog; 2016 Sep; 12(9):e1005885. PubMed ID: 27658293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depot-medroxyprogesterone acetate reduces genital cell-cell adhesion molecule expression and increases genital herpes simplex virus type 2 infection susceptibility in a dose-dependent fashion.
    Quispe Calla NE; Vicetti Miguel RD; Aceves KM; Torres A; Cherpes TL
    Contraception; 2019 Nov; 100(5):397-401. PubMed ID: 31302121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
    Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
    PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium.
    Ildgruben AK; Sjöberg IM; Hammarström ML
    Obstet Gynecol; 2003 Sep; 102(3):571-82. PubMed ID: 12962945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women.
    Wessels JM; Felker AM; Dupont HA; Kaushic C
    Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30154116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception.
    Heffron R; Parikh UM; Penrose KJ; Mugo N; Donnell D; Celum C; Mellors JW; Baeten JM;
    AIDS Behav; 2017 Jul; 21(7):2173-2179. PubMed ID: 27699594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.
    Jain AK
    Contraception; 2012 Dec; 86(6):645-52. PubMed ID: 22541635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depot medroxyprogesterone acetate administration increases cervical CCR5+CD4+ T cells and induces immunosuppressive milieu at the cervicovaginal mucosa.
    Tasker C; Pizutelli V; Lo Y; Ramratnam B; Roche NE; Chang TL
    AIDS; 2020 Apr; 34(5):729-735. PubMed ID: 31972606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.